Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CINC CinCor Pharma > Detailed Quotes

CINC CinCor Pharma

Watchlist
28.930
+0.030+0.10%
Close  01/31 16:00 ET
High
29.055
Open
28.910
Turnover
12.95M
Low
28.840
Pre Close
28.900
Volume
447.47K
Market Cap
1.27B
P/E(TTM)
Loss
52wk High
43.150
Shares
43.76M
P/E(Static)
Loss
52wk Low
10.530
Float Cap
395.99M
Bid/Ask %
-20.00%
Historical High
43.150
Shs Float
13.69M
Volume Ratio
1.63
Historical Low
10.530
Dividend TTM
--
Div Yield TTM
--
P/B
2.44
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.27%
Amplitude
0.74%
Avg Price
28.938
Lot Size
1
Float Cap
395.99M
Bid/Ask %
-20.00%
Historical High
43.150
Shs Float
13.69M
Volume Ratio
1.63
Historical Low
10.530
Dividend TTM
--
P/B
2.44
Dividend LFY
--
Turnover Ratio
3.27%
Amplitude
0.74%
Avg Price
28.938
Lot Size
1
Price Forecast

News

Comment

Company Overview More
CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA.
CEO: Mr. Marc de Garidel
Market: NASDAQ
Listing Date: 01/07/2022
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist